What is the appropriate evaluation and management for a woman with elevated serum calcium?

Evaluation and Management of Elevated Calcium in Women

The first critical step is to confirm true hypercalcemia by measuring ionized calcium or correcting total calcium for albumin, then immediately measure intact parathyroid hormone (PTH) to distinguish PTH-dependent from PTH-independent causes—this single test directs all subsequent evaluation and treatment. 1

Initial Diagnostic Approach

Confirm and Classify Hypercalcemia

• Verify the elevation: Measure ionized calcium (most accurate) or correct total calcium for albumin
• Assess severity:
  • Mild: Total calcium <12 mg/dL (<3 mmol/L)
  • Moderate: 12-14 mg/dL (3-3.5 mmol/L)
  • Severe: >14 mg/dL (>3.5 mmol/L)

Mild hypercalcemia is usually asymptomatic but may cause fatigue and constipation in ~20% of patients. Severe or rapidly developing hypercalcemia causes nausea, vomiting, dehydration, confusion, somnolence, and coma 1.

Measure PTH Immediately

PTH is the single most important test and must be obtained early 1, 2. This stratifies patients into two pathways:

PTH-Dependent (Elevated or Normal PTH):

• Primary hyperparathyroidism (PHPT) - accounts for ~45% of all hypercalcemia cases 1
• Consider parathyroid adenoma (most common), hyperplasia, or rarely carcinoma
• In women of reproductive age, consider pregnancy-related causes

PTH-Independent (Suppressed PTH <20 pg/mL):

• Malignancy - accounts for ~45% of all hypercalcemia cases 1
• Granulomatous disease (sarcoidosis)
• Endocrinopathies (thyrotoxicosis, adrenal insufficiency)
• Medications (thiazides, calcium/vitamin D supplements, lithium)
• Immobilization
• Lactation-associated hypercalcemia (postpartum women) 3, 4

Management Based on Etiology and Severity

Asymptomatic Mild Hypercalcemia with Elevated PTH (PHPT)

For women >50 years with calcium <1 mg/dL above upper normal limit and no skeletal or kidney disease, observation with monitoring is appropriate 1, 5.

Surgical indications for parathyroidectomy include:

• Age <50 years
• Calcium >1 mg/dL above upper limit
• Reduced bone density (T-score <-2.5 or fragility fracture)
• Kidney stones or nephrocalcinosis
• Reduced creatinine clearance (<60 mL/min)

For non-surgical candidates 5:

• Maintain calcium intake at 800-1000 mg/day (not restricted)
• Target vitamin D >30 ng/mL with supplementation if needed
• If calcium >0.25 mmol/L above upper limit: consider cinacalcet
• If osteoporosis present: bisphosphonates (alendronate) or denosumab for radius involvement

Symptomatic or Severe Hypercalcemia (Any Cause)

Initial treatment consists of aggressive IV hydration plus IV bisphosphonates 1.

Specific regimen:

• IV normal saline for volume repletion
• Plus zoledronic acid or pamidronate IV
• For severe hypercalcemia (>14 mg/dL): Add calcitonin for first 48-72 hours only (due to tachyphylaxis) 6

Special circumstances:

• Kidney failure: Use denosumab instead of bisphosphonates; consider dialysis 1
• Vitamin D intoxication or granulomatous disease: Glucocorticoids are primary treatment 1

Hypercalcemia of Malignancy

Treatment with IV bisphosphonate or denosumab is strongly recommended 6. Denosumab is preferred over bisphosphonates for better efficacy 6.

For refractory cases on bisphosphonates, switch to denosumab 6.

Parathyroid Carcinoma (Rare but Important)

Suspect if: Very high calcium (often >14 mg/dL), markedly elevated PTH, palpable neck mass, or vocal cord paralysis.

Management 5:

• Refer to specialized onco-endocrinology center
• En bloc surgical resection without capsule rupture
• Consider postoperative radiotherapy if incomplete resection
• Medical management: Either calcimimetic OR IV bisphosphonate/denosumab 6
• Combination therapy if single agent inadequate

Critical Pitfalls to Avoid

1. Don't assume malignancy in cancer patients: Even women with known breast cancer can have concurrent parathyroid adenoma causing hypercalcemia—always check PTH 7

2. Pregnancy and lactation considerations:

   • Hypercalcemia in pregnancy/postpartum may be lactation-associated (PTHrP-mediated) 3, 4
   • If PHPT diagnosed during pregnancy, parathyroidectomy ideally in second trimester 5
   • Conservative management with hydration and monitoring possible if surgery refused, but requires close surveillance 8

3. Don't miss adrenal insufficiency: Hypercalcemia with hypotension and hyperphosphatemia suggests glucocorticoid deficiency 3

4. Calcitonin is temporary only: Limit to 48-72 hours maximum due to rapid tachyphylaxis 6

5. Monitor for complications: Bisphosphonates and denosumab carry risk of osteonecrosis of jaw and atypical fractures with long-term use

The prognosis for asymptomatic PHPT is excellent with either surgical or medical management, while hypercalcemia of malignancy carries poor survival 1.